| 1 |
35233971 | Overcoming barriers to widespread use of CAR-Treg therapy in organ transplant recipients. | 2022 Jun |
3 |
| 2 |
33940160 | CAR- and TRuC-redirected regulatory T cells differ in capacity to control adaptive immunity to FVIII. | 2021 Sep 1 |
1 |
| 3 |
32525846 | CD19-targeted CAR regulatory T cells suppress B cell pathology without GvHD. | 2020 Jul 23 |
1 |
| 4 |
32823038 | Regulatory T cell therapy: Current and future design perspectives. | 2020 Oct |
1 |
| 5 |
33096321 | Building a CAR-Treg: Going from the basic to the luxury model. | 2020 Dec |
2 |
| 6 |
24097874 | Interleukin-7 mediates selective expansion of tumor-redirected cytotoxic T lymphocytes (CTLs) without enhancement of regulatory T-cell inhibition. | 2014 Jan 1 |
1 |